Gene expression and agent-based modeling improve precision prognosis in breast cancer

Area of Science:

• Computational Biology
• Genomics
• Oncology

Background:

• Predicting breast cancer survival is challenging due to complex gene-cell interactions.
• Existing models often lack the granularity to capture dynamic biological processes.

Purpose of the Study:

• To develop an integrated approach combining gene expression profiling (GEP) and agent-based modeling (ABM) for improved breast cancer survival prediction.
• To create a predictive model that simulates tumor growth and treatment response.
• To enable personalized treatment strategies through in-silico experimentation.

Main Methods:

• Gene expression profiling (GEP) to identify key genes in breast cancer.
• Development of a mathematical model to represent gene-influenced cell behavior.
• Agent-based modeling (ABM) to simulate tumor dynamics and treatment efficacy.
• Validation of the ABM against clinical patient data and comparison with existing predictive models.

Main Results:

• The integrated GEP-ABM approach demonstrated potential for enhanced accuracy in survival prediction.
• Agent-based modeling successfully simulated tumor growth and response to various therapeutic interventions.
• The model's predictive capabilities were validated using real-world patient data.

Conclusions:

• Combining GEP with ABM offers a powerful framework for improving breast cancer survival prediction.
• Agent-based modeling facilitates the mathematical analysis of cellular interactions, paving the way for personalized medicine.
• This research supports the development of more effective and tailored breast cancer treatments.